Skip to main content
Clinical Trials/CTRI/2020/11/029120
CTRI/2020/11/029120
Suspended
未知

To assess the outcome of Acanthamoeba keratitis on combination of topical Biguanides and oral Miltefosine.

V Prasad Eye Instituta0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B601- Acanthamebiasis
Sponsor
V Prasad Eye Instituta
Status
Suspended
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
V Prasad Eye Instituta

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients with age more than 18 years
  • 2\.Microbiologically proven Acanthamoeba keratitis
  • 3\.Patients willing to participate and follow up.

Exclusion Criteria

  • 1\.Patients with age less than 18 years
  • 2\.Pregnant and lactating females
  • 3\.Patients who are likely to be pregnant are relative contraindicated.
  • 4\.Patient not willing to participate and follow up
  • 5\.Patients with known allergy to Miltefosine
  • 6\.Patients with epithelial or sub epithelial keratitis with only anterior stroma involvement with less than 4 mm.

Outcomes

Primary Outcomes

Not specified

Similar Trials